Shanghai MicuRx Pharmaceutical Co Ltd Sustainability Reports
The company discovers, develops, and commercializes small-molecule innovative drugs focusing on anti-infection therapeutics. Its pipelines mainly target drug-resistant Gram-positive and Gram-negative bacterial infections.
Sector: Manufacturing
Country: China
Exchange: Shanghai Stock Exchange
FIGI: BBG00PZ2SS18
2 reports from 2024 to 2025